CHARMAINE WEBLEY: Open Payments
NPI 1376014902 · SPRINGFIELD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,492 in 184 payments from 16 companies in 2025. Trend: 2023 $2,435 · 2024 $3,300 · 2025 $4,492
Food & beverage: $4,307Education: $185
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 55 | $1,122 |
| ABBVIE INC. | 28 | $879 |
| Neurocrine BioSciences, Inc. | 26 | $581 |
| E.R. Squibb & Sons, L.L.C. | 15 | $463 |
| Otsuka America Pharmaceutical, Inc. | 9 | $332 |
| Janssen Pharmaceuticals, Inc | 11 | $249 |
| Axsome Therapeutics, Inc. | 8 | $166 |
| Lundbeck LLC | 8 | $165 |
| Alkermes, Inc. | 5 | $160 |
| Lilly USA, LLC | 3 | $87 |
Products named: VRAYLAR, INGREZZA, UZEDY, COBENFY, AUSTEDO XR, REXULTI, SPRAVATO, Auvelity.
Industry payments across MA — which companies pay providers there.
